Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-05-07

Treatment of diabetes by islet cell transplantation

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati sfruttabili

The long term goal of this programme is to prevent the development of chronic complications in diabetic patients by implantation of an insulin producing beta cell graft. Our working hypothesis is that successful transplantation of beta cells requires grafts with selected size, composition and function. The biologic properties of beta cell grafts should be characterised and adjusted to the metabolic and immunologic status of the recipient. This type of graft should increase the efficacy of accompanying measures aiming at graft survival and/or metabolic correction. Since the supply of human beta cells is insufficient for experimental or therapeutic transplantation programmes in diabetes, we propose additional core activities for the production of beta cell grafts from two alternate sources. The first approach aims at the generation of human beta cells from stem cells which are to be purified from pancreatic duct cells that will be isolated from young donors. The second approach involves mass isolation of islet or beta cells from foetal porcine pancreata and their encapsulation in bioartificial devices which protect the xenogeneic donor tissue against host attack.

È in corso la ricerca di dati su OpenAIRE...

Si è verificato un errore durante la ricerca dei dati su OpenAIRE

Nessun risultato disponibile

Il mio fascicolo 0 0